Education
University of Warwick, UK (MD)
UCLA (Ph.D. Oncology)
University of New England, Aust (MBA)
Bio
Dr. Smith is a global pharma/biotech executive.
Dr. Smith has held senior/executive roles in numerous privately held and publicly traded life sciences firms. She has also acted as a clinical and/or regulatory advisor and as a board/executive advisor.
Her expertise is broad and deep in the following areas:
- Research & Development
- Clinical & Scientific Leadership
- Clinical Trial Strategy
- International Medical Affairs
- Mergers & Acquisitions
- Global Regulatory Approvals
Relevant Experience
Deep experience with clinical trial and regulatory risk issues, OIG and Corporate Integrity Agreements. Has extensive due diligence experience. Also served on audit committee, nominating and governance, and as Chair of compensation committees of boards.
- Consultant (2018 – ongoing)
Chief Medical Officer, Corporate Advisor - Emergent Biosolutions (2020 – 2021)
Chief Medical Officer - Medeor Therapeutics (2019 – 2020)
CEO and CMO - Eliminate Cancer (2018 – 2019)
Chief Executive Officer - Jazz Pharma (2015 – 2018)
EVP, Global Head, R&D - Allergan (2011 – 2015)
SVP & Global TA Head, R&D - AstraZeneca (2008 – 2011)
VP, Global Development - Bristol-Myers Squibb (2002 – 2008)
- Boron Molecular ▪ Pfizer ▪ Merck (1995 – 2001)
Education
University of Warwick, UK (MD)
UCLA (Ph.D. Oncology)
University of New England, Aust (MBA)
AlixPartners’ professionals work closely with several Academic Affiliates who bring deep subject matter expertise in niche areas of economics, financial accounting, and corporate governance.